Cheung Kevin, Walley Kempland C, Rozental Tamara D
Division of Plastic Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, ST 10, Boston, MA 02215, USA.
Department of Orthopedics, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, ST 10, Boston, MA 02215, USA.
Hand Clin. 2015 May;31(2):345-54. doi: 10.1016/j.hcl.2015.01.005.
This evidence-based article discusses the current management options of Dupuytren disease and strategies to avoid and manage any potential complications. Treatment options include fasciectomy, needle fasciotomy/aponeurotomy, and collagenase injection. Complications include digital nerve and artery injury, flexor tendon injury, skin fissures and wound healing complications, hematoma, infection, flare reaction/complex regional pain syndrome, and recurrence. Complication rates, prevention, and management differ with each treatment modality. A detailed understanding of each of these options allows hand surgeons to select the most appropriate treatment for each patient.
这篇循证医学文章讨论了杜普伊特伦挛缩病的当前治疗选择以及避免和处理任何潜在并发症的策略。治疗选择包括筋膜切除术、针式筋膜切开术/腱膜切开术和胶原酶注射。并发症包括指神经和动脉损伤、屈肌腱损伤、皮肤裂伤和伤口愈合并发症、血肿、感染、 flare反应/复杂性区域疼痛综合征以及复发。每种治疗方式的并发症发生率、预防措施和处理方法各不相同。对手外科医生来说，详细了解每种选择有助于为每位患者选择最合适的治疗方法。
